膜性脏病:病原和治疗方法
Mengqiong Wang1, Jingjuan Yang1, Xin Fang1
1Department of Nephrology Center for Regeneration and Aging Medicine The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine Zhejiang University Yiwu China.
MedComm
|July 1, 2024
概括
膜性病 (MN) 是一种常见的自身免疫性病. 最近关于脂酶A2受体点的研究有助于对这种疾病的理解和治疗.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 膜性病 (MN) 是成年人性综合征的主要原因.
- 百分之八十的MN病例是异常发病的; 其他是感染,恶性瘤或自身免疫疾病的次要原因.
- 脑膜炎的进展可能导致末期脏疾病,突出显示需要有效管理.
研究的目的:
- 审查膜性病症病理生理学的最新进展.
- 探索病原和治疗策略的新兴发展.
- 综合当前的研究,以更好地理解和管理MN.
主要方法:
- 对最近的研究结果和临床见解进行文献综述.
- 综合了有关病理生理学,临床表现,诊断,治疗和预后的数据.
- 专注于对病原和治疗干预的新见解.
主要成果:
- 鉴定了脂酶A2受体作为一个关键的向抗原在mn.
- 了解驱动MN的自身免疫机制的进展.
- 新兴的治疗策略旨在阻止疾病的进展.
结论:
- 向脂酶A2受体代表了MN管理的重大转变.
- 对病原体的进一步研究对于开发新疗法至关重要.
- 更好地了解MN病理生理学和治疗方法可以改善患者的治疗结果.
相关概念视频
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
Nephrons
2.3K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.3K
Renal Corpuscle
1.9K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.9K
Pulmonary Tuberculosis II
217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178


